Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.69 (
APC
)
16,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
beta-Thalassemic patients exhibit an increased frequency of thrombotic events but most patients with heterozygous beta-
thalassemia minor
are asymptomatic and no single case with beta-
thalassemia minor
and concurrent stroke was reported. We present a 15-year-old boy with heterozygous beta-
thalassemia minor
who developed recurrent transient ischemic attacks as documented with repeated brain SPECTs whereas structural neuro-imaging was not contributory. The patient exhibited resistance to
activated protein C
due to heterozygosity for factor V Leiden as well as slightly decreased plasma levels of
protein C
and S. This unique association of risk factors might have caused clinically significant thrombophilia resulting in recurrent cerebrovascular events. This case report underlines the thrombogenic risk of heterozygous beta-
thalassemia minor
in children heterozygous for factor V Leiden mutation. We therefore suggest to screen for thrombophilia in children with beta-
thalassemia minor
when thromboembolism-related phenomena occur. This case also demonstrates that brain perfusion SPECT is a useful and sensitive tool for detecting cerebrovascular events in patients with hemoglobinopathies.
...
PMID:Recurrent transient ischemic attacks in a 15-year-old boy with beta-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis. 1289 4